Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of oral, injectable, and inhaled N-acetylcysteine in hospitalized COPD patients with concurrent pneumonia
IRCT20241218064092N1Phase 2Completed
- Sponsor
- Zanjan University of Medical Sciences
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of acetylcysteine in chronic obstructive pulmonary disease (COPD) and pneumonia, sponsored by Zanjan University of Medical Sciences. Started Jan 2025; status: completed.
02
Drugs
acetylcysteine
03
Conditions
chronic obstructive pulmonary disease (COPD)pneumonia
Beyond the preview
Go deeper on IRCT20241218064092N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241218064092N1.